Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib in Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma
NCT00066508Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- May 2003
- Primary completion
- Jul 2005
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in diffuse large B-cell lymphoma (DLBCL), sponsored by UCLA Jonsson Comprehensive Cancer Center. Started May 2003; status: completed.
02
Drugs
bortezomib
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00066508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00066508.